EF
VRTX icon

Empowered Funds’s Vertex Pharmaceuticals VRTX Stock Holding History

Empowered Funds’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.9M Buy
50,197
+8,460
+20% +$3.75M 0.13% 152
2026
Q1 		$18.6M Buy
41,737
+26,931
+182% +$12.6M 0.12% 176
2025
Q4 		$6.71M Buy
14,806
+1,223
+9% +$527K 0.11% 199
2025
Q3 		$5.32M Buy
13,583
+3,761
+38% +$1.57M 0.05% 466
2025
Q2 		$4.37M Buy
9,822
+4,632
+89% +$2.13M 0.05% 480
2025
Q1 		$2.52M Sell
5,190
-2,629
-34% -$1.23M 0.04% 630
2024
Q4 		$3.15M Sell
7,819
-4,786
-38% -$2.22M 0.05% 537
2024
Q3 		$5.86M Sell
12,605
-17,482
-58% -$8.4M 0.09% 313
2024
Q2 		$14.1M Buy
30,087
+23,348
+346% +$10.1M 0.24% 72
2024
Q1 		$2.82M Sell
6,739
-5,287
-44% -$2.24M 0.05% 493
2023
Q4 		$4.89M Buy
12,026
+9,836
+449% +$3.63M 0.12% 237
2023
Q3 		$762K Buy
2,190
+386
+21% +$135K 0.02% 767
2023
Q2 		$635K Buy
1,804
+652
+57% +$220K 0.02% 748
2023
Q1 		$363K Sell
1,152
-8,517
-88% -$2.55M 0.02% 433
2022
Q4 		$2.79M Buy
9,669
+2,334
+32% +$711K 0.18% 157
2022
Q3 		$2.12M Buy
+7,335
New +$2.11M 0.21% 106

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Empowered Funds's VRTX Position: Q2 2026 in Review

Empowered Funds increased its Vertex Pharmaceuticals (VRTX) stake by 20% in Q2 2026, buying an estimated $3.75M and bringing the position to 50,197 shares worth $24.9M. The position accounts for 0.13% of the portfolio, ranked #152.

Empowered Funds first reported a position in VRTX in Q3 2022 and has held it in 16 quarters since. 1,754 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Empowered Funds held 50,197 shares of Vertex Pharmaceuticals worth $24.9M as of Q2 2026.
  • Empowered Funds bought 8,460 Vertex Pharmaceuticals shares in Q2 2026, an estimated $3.75M.
  • Vertex Pharmaceuticals made up 0.13% of Empowered Funds's portfolio in Q2 2026, its #152 holding.
  • Empowered Funds first reported a position in Vertex Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • 1,754 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.